Contrary to common belief, men age 75 and older are diagnosed with late-stage and more aggressive prostate cancer and thus die from the disease more often than younger men, according to a University of Rochester analysis published online this week in the journal Cancer. The study is particularly relevant in light of the recent controversy² about prostate cancer screening. Earlier this month a government health panel said that healthy men age 50 and older should no longer be routinely tested for prostate cancer because the screening test in its current form does not save lives and sometimes leads to needless suffering and overtreatment. Patient advocates（主张，提倡） and many clinicians disagreed with the finding.

Although the Rochester study does not address screening directly it does raise questions about the benefits of earlier detection among the elderly.

"Especially for older people, the belief is that if they are diagnosed with prostate cancer it will grow slowly and they will die of something else," said lead author Guan Wu, M.D., Ph.D., assistant professor of Urology and of Pathology and Laboratory Medicine at the University of Rochester Medical Center.

"We hope our study will raise awareness³ of the fact that older men are actually dying at high rates from prostate cancer," he said. "With an aging population it is important to understand this, as doctors and patients will be embarking⁴ on more discussions about the pros¹ and cons⁵ of treatment."

Wu and colleagues studied the largest national cohort of cancer patients, called the Surveillance, Epidemiology, and End Results (SEER) database. They analyzed⁶ 464,918 records of men diagnosed with prostate cancer between 1998 and 2007, known as the "PSA era" because of a strong inclination⁷（倾向，爱好） to recommend the PSA test during that time.

(The prostate-specific antigen or PSA is a protein produced by the prostate gland⁸, which can be measured in the blood. An elevated PSA is associated with cancer and other noncancerous prostate conditions.)

The analysis showed that when age groups are broken down into smaller sections, men 75 or older represented only 16 percent of the male population above age 50 and 26 percent of all cases of prostate cancer -- but 48 percent of cases of metastatic（转移性的） disease at diagnosis⁹ and 53 percent of all deaths. In general, higher grade cancer seemed to increase with age, the study said.